Peggy Liu Kreyche
About Peggy Liu Kreyche
Peggy Liu Kreyche is a Research Scientist at Bristol-Myers Squibb, specializing in biotransformation support for drug discovery and development.
Title
Peggy Liu Kreyche holds the title of Research Scientist. She is currently employed at Bristol-Myers Squibb, a leading global biopharmaceutical company.
Company
Peggy Liu Kreyche is actively engaged as a Research Scientist at Bristol-Myers Squibb. The company is known for its focus on innovative medicines for serious diseases, making strides in oncology, cardiovascular disease, immunoscience, and fibrosis.
Background
Since 1999, Peggy Liu Kreyche has been providing biotransformation support for drug discovery and development. Throughout her career, she has gained in-depth experience in various aspects of drug metabolism and pharmacokinetics.
Specialization in Drug Metabolism
Peggy Liu Kreyche is specialized in radiolabeled ADME studies, metabolite profiling, and identification. Her work involves detailed investigations into drug metabolism-related pharmacokinetics (PK), drug-drug interactions (DDI), and toxicity issues, leveraging her expertise in both in vivo and in vitro metabolism.